Liver failure and liver disease

Hepatology

Volumn 43, Issue 2 SUPPL. 1, 2006, Pages

  Elias, Elwyn ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PIOGLITAZONE; ROSIGLITAZONE; TERLIPRESSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

BLEEDING; BRAIN FUNCTION; CLINICAL TRIAL; DISEASE COURSE; HEPATIC VEIN; HEPATORENAL SYNDROME; HUMAN; INSULIN RESISTANCE; LIVER DISEASE; LIVER FAILURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; VENOUS PRESSURE;

FATTY LIVER; HEPATIC VEINS; HUMANS; INTRACRANIAL HYPERTENSION; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; VENOUS PRESSURE;

EID: 33644554523     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21041     Document Type: Review

References (28)

1. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. HEPATOLOGY 2003;37:1286-1292.
2. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. HEPATOLOGY 2003;37:909-916.
3. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. HEPATOLOGY 2002;35:898-904.
4. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with non-alcoholic steatohepatitis. HEPATOLOGY 2003;37:544-550.
5. Emery MG, Fisher JM, Chien JY, Kharasch ED, Dellinger EP, Krowdley KV, et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. HEPATOLOGY 2003;38:428-435.
6. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. HEPATOLOGY 2003;38:999-1007.
7. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002;35:373-379.
8. Marchesini G, Forlani G. NASH: From liver diseases to metabolic disorders and back to clinical hepatology. HEPATOLOGY 2002;35:497-499.
9. Chitturi S, Farrell G, Frost E, Kriketos A, Lin R, Liddle C, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? HEPATOLOGY 2002;36:403-409.
10. Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. HEPATOLOGY 2005;41:753-760.
11. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-α or adiponectin? HEPATOLOGY 2004;40:46-54.
12. Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, et al. Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease. HEPATOLOGY 2004;42:1175-1183.
13. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone. HEPATOLOGY 2003;38:1008-1017.
14. Promrat K, Eutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. HEPATOLOGY 2004;39:188-196.
15. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss HEPATOLOGY 2004;39:1647-1654.
16. Ming Z, Smyth DD, Lautt WW. Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: Role of adenosine HEPATOLOGY 2002;35:167-175.
17. Ripoll C, Bañares R, Rincón D, Catalina M-V, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the meld era. HEPATOLOGY 2005;42:793-801.
18. Ruiz-del-Arbol E, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. HEPATOLOGY 2005;42:439-447.
19. Bureau C, Péron J-M, Alric L, Morales J, Sanchez J, Barange K, et al. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. HEPATOLOGY 2002;36:1361-1366.
20. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. HEPATOLOGY 2004;40:793-801.
21. Shawcross DL, Davies NA, Mookerjee RP, Hayes PC, Williams R, Lee A, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. HEPATOLOGY 2004;39:471-475.
22. Balata S, Damink SWMO, Ferguson K, Marshall I, Hayes PC, Deutz, NEP, et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. HEPATOLOGY 2003;37:931-939.
23. Damink SWMO, Jalan R, Deutz NEP, Redhead DN, Dejong CHC, Hynd P, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. HEPATOLOGY 2003;37:1277-1285.
24. Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS. Cerebral microdialysis in patients with fulminant hepatic failure. HEPATOLOGY 2002;36:1333-1340.
25. Zwingmann C, Chatauret N, Leibfritz D, Butterwotth RF. Selective increase of brain lactate synthesis in experimental acute liver failure: Results of a [1H-13C] nuclear magnetic resonance study. HEPATOLOGY 2003;37:420-428.
26. Restuccia T, Gómez-Ansón B, Guevara M, Alessandria C, Torre A, Alayrach ME, et al. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. HEPATOLOGY 2004;39:1613-1622.
27. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure HEPATOLOGY 2004;39:464-470.
28. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. HEPATOLOGY 2002;36:395-402.